Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis

World News: . []

DUBLIN Ireland and LINK  Mass July 30 2019 GLOBE NEWSWIRE -- Nasdaq ALKS and LINK  BIIB today announced positive LINK  results from EVOLVE-MS-2 a large randomized double-blind five-week Phase 3 study of LINK  fumarat e, an i...

More news and information about Biogen Inc.

Published By:

Globe Newswire: 12:30 GMT Tuesday 30th July 2019

Published: .

Search for other references to "diroximel" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us